Literature DB >> 7928187

Free radical scavenging and antioxidant activity of allopurinol and oxypurinol in experimental lens-induced uveitis.

A J Augustin1, T Böker, S H Blumenröder, J Lutz, M Spitznas.   

Abstract

PURPOSE: In addition to the inhibition of xanthine oxidase, allopurinol is known to act, dependent on the dose, as a free radical scavenger, an antioxidant, and a "scavenger" of hypochlorous acid. This activity was investigated using a model of lens-induced uveitis.
METHODS: Lipid peroxides (LPO) were determined in aqueous humor and in retinal tissue. Reduced and oxidized glutathione (GSH and GSSG) of the aqueous humor and myeloperoxidase (MPO) activity in the iris-ciliary body complex were analyzed. Allopurinol and oxypurinol concentrations were determined by high-performance liquid chromatography in aqueous humor and retinal tissue of both control eyes and eyes with uveitis. These measurements were performed 6 hours after intravenous application of allopurinol.
RESULTS: In lens-induced uveitis, LPO are significantly elevated, GSH is reduced, and GSSG and MPO are increased. A xanthine oxidase inhibition dose (< 10 mg/kg body weight) of allopurinol showed no effects on oxidative tissue damage in the model used in this study. Higher doses, however, were able to reduce the oxidative damage. Allopurinol (20 mg/kg body weight) had slight effects on GSH and GSSG. All parameters improved using a dose of 50 mg/kg body weight; a dose of 100 mg/kg body weight only showed additional improvement in GSH and GSSG. There was no further change in the other parameters. Allopurinol and oxypurinol concentrations in aqueous humor and retinal tissue showed a dose dependency reaching scavenger concentrations after application of 50 mg/kg body weight of allopurinol.
CONCLUSIONS: These results suggest that the xanthine oxidase mechanism plays a minor role in the oxidative tissue damage due to lens-induced uveitis. Free radicals and oxidants are generated by activated leukocytes; therefore, the effect of higher doses of allopurinol is due to its free radical scavenging and antioxidative activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7928187

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

Review 1.  Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal.

Authors:  Tuhina Neogi; Jacob George; Sushma Rekhraj; Allan D Struthers; Hyon Choi; Robert A Terkeltaub
Journal:  Arthritis Rheum       Date:  2012-02

2.  Effects of allopurinol and steroids on inflammation and oxidative tissue damage in experimental lens induced uveitis: a biochemical and morphological study.

Authors:  A J Augustin; M Spitznas; W Sekundo; F Koch; J Lutz; D Meller; F H Grus; A Wegener; S H Blumenröder
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

3.  Allopurinol ameliorates thioacetamide-induced acute liver failure by regulating cellular redox-sensitive transcription factors in rats.

Authors:  Ulvi Demirel; Mehmet Yalniz; Cem Aygün; Cemal Orhan; Mehmet Tuzcu; Kazim Sahin; Ibrahim Hanifi Ozercan; Ibrahim Halil Bahçecioğlu
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

4.  NADPH oxidase plays a central role in cone cell death in retinitis pigmentosa.

Authors:  Shinichi Usui; Brian C Oveson; Sun Young Lee; Young-Joon Jo; Tsunehiko Yoshida; Akiko Miki; Katsuaki Miki; Takeshi Iwase; Lili Lu; Peter A Campochiaro
Journal:  J Neurochem       Date:  2009-05-30       Impact factor: 5.372

Review 5.  Hyperuricosuric calcium urolithiasis.

Authors:  Orson W Moe; Li Hao Richie Xu
Journal:  J Nephrol       Date:  2018-01-24       Impact factor: 3.902

6.  Immunomodulating activity of allopurinol in experimental lens-induced uveitis.

Authors:  F H Grus; A J Augustin; C W Zimmermann; M Spitznas; W Sekundo; J Lutz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-02       Impact factor: 3.117

Review 7.  Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Authors:  Pál Pacher; Alex Nivorozhkin; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

8.  Enhanced expression and activity of Nox2 and Nox4 in the macula densa in ANG II-induced hypertensive mice.

Authors:  Jie Zhang; Kiran Chandrashekar; Yan Lu; Yanhua Duan; Phillip Qu; Jin Wei; Luis A Juncos; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-27

9.  Oxidative reactions in the tear fluid of patients suffering from dry eyes.

Authors:  A J Augustin; M Spitznas; N Kaviani; D Meller; F H Koch; F Grus; M J Göbbels
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-11       Impact factor: 3.117

10.  Xanthine Oxidoreductase Inhibitors.

Authors:  Keeran Vickneson; Jacob George
Journal:  Handb Exp Pharmacol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.